21.6 C
Delhi
Saturday, November 28, 2020

IAVI, Merck, and Serum Institute of India to develop monoclonal antibodies for Covid

- Advertisement -

IAVI, Merck, and Serum Institute of India to develop monoclonal antibodies for CovidNew Delhi, Oct 22 (IANS) IAVI, a non-profit scientific research organisation and Serum Institute of India announced an agreement with Merck to develop SARS-CoV-2 neutralising monoclonal antibodies (mAbs) co-invented by IAVI and Scripps Research as innovative interventions to address the Covid-19 pandemic.

The agreement builds on the advanced antibody discovery and optimization expertise of IAVI and Scripps Research, gained from years of experience in HIV broadly neutralising antibody research and development, and on Merck’s and Serum Institute’s significant capabilities in design and scale up of accelerated manufacturing processes for mAb production. The global development plan is being led by the three organisations in partnership.

The two companies have broad networks across complementary geographic areas that will be crucial to reach given the worldwide spread of Covid-19.

If the highly potent and broadly cross-reactive SARS-CoV-2 neutralising antibody candidates being advanced through this partnership are shown to be efficacious in clinical trials, either as a single antibody or a potential combination of both candidates, Merck will lead commercialisation in developed countries.

Serum Institute has a proven track record of more than 50 years in developing affordable medicines and is the world’s largest producer of vaccines. Serum Institute will lead global manufacturing as well as commercialisation in low- and middle-low-income countries, including India.

“We’re acutely aware of the tremendous potential for monoclonal antibodies to be used in Covid-19 response. By combining the scientific achievements of IAVI and Scripps Research with our partners’ development, manufacturing, and distribution expertise, we are hopeful that this partnership will result in globally accessible antibodies that are available to all who can benefit from them,” said Mark Feinberg, President and CEO of IAVI.

Bel?n Garijo, Vice Chair of the executive board and deputy CEO, Merck, as well as CEO Healthcare, said, “Together with IAVI and Serum Institute, we look forward to demonstrating the potential application of these monoclonal antibodies in the management of Covid-19. We share a common purpose to accelerate this promising science and deliver effective solutions that address global challenges presented by this pandemic”.

READ ALSO:  Schooling gets over but learning process continues for ages: PM Modi

“I am extremely pleased that we have joined forces with IAVI and Merck in the fight against Covid-19 with the aim of developing monoclonal antibodies for global access. Given the breadth and scale of our technology and our long-standing devotion to improving health especially in low-income countries, I am confident that we and our partners are on a productive path that will lead to a much-needed, globally available tool for Covid-19 treatment and possibly prevention,” said Adar Poonawalla, CEO, Serum Institute.

Neutralising mAbs against SARS-CoV-2 are widely considered to be promising candidates for Covid-19 treatment and prevention.

Encouraging results for Covid-19 antibody treatment have emerged from preclinical research and from initial clinical trials.

Not only are innovative therapies such as SARS-CoV-2 neutralising antibodies urgently needed for immediate pandemic response, they will likely also continue to be needed even after an effective vaccine is available.

mAbs have the potential to play an important complementary role to Covid-19 vaccines both for treatment and potentially for prevention, especially for those individuals who, due to age or medical conditions, may not benefit from vaccination.

Given that many experts speculate that Covid-19 will become an endemic, or permanently circulating, disease, and given the severity of symptoms in a significant proportion of people affected, effective therapies will be necessary to treat those who remain unvaccinated or whom vaccination does not protect.

Scientists at IAVI’s (NAC) centre based at Scripps Research, along with fellow immunologists at Scripps Research, were part of a team that identified antibodies from the blood of recovered Covid-19 patients that are capable of potently neutralising SARS-CoV-2, the virus that causes Covid-19.

Animals that received these neutralizing antibodies were protected against disease after challenge with SARS-CoV-2. The results were published in Science in June 2020.

The portfolio of mAbs identified by IAVI and Scripps Research scientists and their partners provides the foundation for a comprehensive program with potential application to COVID-19 treatment and prevention as well as to other coronaviruses that may arise or re-emerge in the future.

READ ALSO:  CAIT urged centre to extend the lockdown period to contain Covid-19

Dennis Burton, Professor and Chair of the Department of Immunology and Microbiology at Scripps Research and scientific director of the IAVI NAC said, “The accelerated discovery of highly potent SARS-CoV-2 neutralising antibodies by IAVI and Scripps Research scientists was achieved by a tremendous collaborative effort of a team committed to translating state-of-the-art monoclonal antibody science into public health interventions that we all hope will have an important role in ameliorating the individual and societal impact of the Covid-19 pandemic.”

Under IAVI’s agreement with Merck and Serum Institute, the partners will conduct an accelerated, integrated programme of preclinical and clinical research to evaluate the antibodies for treatment of Covid-19. A Phase I clinical trial is expected to start early in 2021. Should the mAb candidates being developed be shown to be safe and efficacious, Merck and Serum Institute will help ensure that the therapy is rapidly and widely available and accessible.

READ ALSO:  SC refers Sabarimala issue to larger 7-judge bench

Joining the partners in this development effort are two highly regarded companies with unique capabilities. Syngene International Ltd., based in Bengaluru, India, is Asia’s largest contract research and manufacturing organisation. Through their innovation-focused research and development capabilities they are a collaborating to support clinical development of the SARS-CoV-2 mAb candidates.

ATUM, a California-based bioengineering company, has utilised its Leap-In Transposase Platform to develop stable cell lines needed for the manufacture of the SARS-CoV-2 antibody candidates being advanced via this collaboration. This effort is enabling the rapid and robust transition from research to clinical development.

The collaboration among IAVI, Serum Institute of India, and Merck is the kind of innovative partnership identified in the call to action that could set an important precedent for enabling affordable access to SARS-CoV-2 mAbs in LMICs and potentially be applied more widely to mAbs for a range of infectious and non-communicable diseases.

Source: IANS

India Updates
India Updates is an independent news & Information website. Follow us for regular updates on News and Information.

Follow Us On

Related News

Total FDI inflow during Q2 FY21 stands at $28.1 bn

New Delhi, Nov 28 (IANS) The total foreign direct investment (FDI) during the second quarter of financial year 2020-21 stood at $28.10 billion, out...

Apple patents new MacBook Touch Bar with Force Touch technology

San Francisco, Nov 28 (IANS) Apple is reportedly planning to add Force Touch sensors to the OLED Touch Bar on a future MacBook Pro.A...

Huawei to use liquid lens in its flagship phones: Report

Beijing, Nov 28 (IANS): Chinese smartphone maker Huawei is reportedly in the final stage of testing the liquid lens for flagship phones which is supposed...

Farmers’ stir chokes various points near Delhi-Haryana border

New Delhi, Nov 28 (IANS) The traffic movement at various points near the Delhi-Haryana border was affected on Saturday as farmers continued to lay siege...

Bharat Biotech working with ICMR for speedy progress: PM

Hyderabad, Nov 28 (IANS) Prime Minister Narendra Modi said Bharat Biotech, a city-based pharmaceutical company, is closely working with the Indian Council of Medical...

Farmers continue to protest at Tikri border, situation peaceful

New Delhi, Nov 28 (IANS) A day after their stand-off with security forces over entry into Delhi, farmers who have travelled from Punjab and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Trending Topics In India

Covid 19 India Updates

Kerala, Maha, Delhi among 6 states with 61% new Covid cases detected every day

By Rajnish Singh, (IANS) Kerala, Maharashtra and Delhi are among top six states which are accountable for contributing 61 per cent new Covid-19 cases on daily basis in India,...

Kerala, Maha, Delhi among 6 states with 61% new Covid cases detected every day

By Rajnish Singh, (IANS) Kerala, Maharashtra and Delhi are among top six states which are accountable for contributing 61 per cent new Covid-19 cases on daily basis in India,...

Looking at vaccine manufacture, delivery ecosystem: Harsh Vardhan

New Delhi, Nov 25 (IANS) At a time the world is racing against time to find a safe and effective vaccine against Covid-19, Union...

Apollo Hospitals gearing up to give one million vaccines a day

New Delhi, Nov 25 (IANS) Apollo Hospitals are gearing up to give one million vaccines a day once it is available across India through...

Over 88% Indians know at least one Covid infected person: Survey

New Delhi, Nov 25 (IANS) With over nine million coronavirus cases in India, 88 per cent citizens now have one or more contacts in...

Covid-19 second wave may be a tsunami, warns Thackeray

Mumbai, Nov 22 (IANS) With Covid-19 cases again surging in some parts of the the country, Maharashtra Chief Minister Uddhav Thackeray on Sunday hinted...

Trending News In India

ICMR approves dry swab RT-PCR method for Covid detection

New Delhi, Nov 27 (IANS) The simple and fast method of dry swab-direct RT-PCR, developed by CSIR's constituent lab Centre for Cellular and Molecular...

Apple patents new MacBook Touch Bar with Force Touch technology

San Francisco, Nov 28 (IANS) Apple is reportedly planning to add Force Touch sensors to the OLED Touch Bar on a future MacBook Pro.A...

Huawei to use liquid lens in its flagship phones: Report

Beijing, Nov 28 (IANS): Chinese smartphone maker Huawei is reportedly in the final stage of testing the liquid lens for flagship phones which is supposed...

Farmers’ stir chokes various points near Delhi-Haryana border

New Delhi, Nov 28 (IANS) The traffic movement at various points near the Delhi-Haryana border was affected on Saturday as farmers continued to lay siege...

Bharat Biotech working with ICMR for speedy progress: PM

Hyderabad, Nov 28 (IANS) Prime Minister Narendra Modi said Bharat Biotech, a city-based pharmaceutical company, is closely working with the Indian Council of Medical...

Farmers continue to protest at Tikri border, situation peaceful

New Delhi, Nov 28 (IANS) A day after their stand-off with security forces over entry into Delhi, farmers who have travelled from Punjab and...

Trending Showbiz

Indian Award shows should include films released on OTT: Bhumi

Mumbai, Nov 27 (IANS) Actress Bhumi Pednekar is not new to the web space, her film Dolly Kitty Aur Woh Chamakte Sitare dropped on...

Sanjay Dutt’s new film ‘Torbaaz’ discusses terrorism with human angle

Mumbai, Nov 26 (IANS) Filmmaker Girish Malik, who directs Sanjay Dutt in his new film Torbaaz, says he wanted to show a story of...

Gear up for India’s first ever OTT awards

By Puja Gupta, (IANS) Fans across the globe now have a chance to engage with OTT entertainment content and stars digitally; they can and...

Malayalam film ‘Jallikattu’ is India’s entry for Oscars 2021

Mumbai, Nov 25 (IANS) The Malayalam film, Jallikattu, has been selected as the official Indian entry in the Best International Feature Film category at...

Kabaddi is a sport, can’t be played well without teamwork: Abhishek Bachchan

Mumbai, Nov 24 (IANS) Abhishek Bachchan, who owns the Kabaddi team Jaipur Pink Panthers, says the upcoming docu-feature, Sons Of The Soil: Jaipur Pink...

Television actor Ashiesh Roy passed away

Mumbai, Nov 24 (IANS) Television actor Ashiesh Roy passed away in Mumbai early on Tuesday. The Sasural Simar Ka actor died of kidney failure...

Trending Sports

Premier Badminton League season 6 postponed due to Covid-19

New Delhi, Nov 27 (IANS) The sixth season of the Premier Badminton League (PBL), which was scheduled to take place in late December, has...

Kohli hits out at team for not getting into ODI mode from T20

New Delhi, Nov 27 (IANS) India skipper Virat Kohli hit out at his team for not getting into 50-over format rhythm for the ongoing three-match...

Australia outscore India, take 1-0 lead in ODI series

Sydney, Nov 27 (IANS) Australia defeated India by 66 runs in the first One-day International at the Sydney Cricket Ground on Friday to take...

Excited to be back playing in front of crowds: Kohli

Sydney, Nov 26 (IANS) Rival skippers Virat Kohli of India and Aaron Finch of Australia on Thursday expressed relief and joy at the prospect...

1986 World Cup quarter-final: Maradona becomes immortal

New Delhi, Nov 26 (IANS) “I dream of being able to score another goal against the English, with the right hand this time!” said Diego...

Football legend Diego Maradona, 60, dead

Buenos Aires, Nov 25 (IANS) Football legend Diego Maradona has died, aged 60, according to Argentine media reports. He had been discharged from hospital...

Latest Trending News In India

Apple patents new MacBook Touch Bar with Force Touch technology

San Francisco, Nov 28 (IANS) Apple is reportedly planning to add Force Touch sensors to the OLED Touch Bar on a future MacBook Pro.A...

Huawei to use liquid lens in its flagship phones: Report

Beijing, Nov 28 (IANS): Chinese smartphone maker Huawei is reportedly in the final stage of testing the liquid lens for flagship phones which is supposed...

Farmers’ stir chokes various points near Delhi-Haryana border

New Delhi, Nov 28 (IANS) The traffic movement at various points near the Delhi-Haryana border was affected on Saturday as farmers continued to lay siege...

Bharat Biotech working with ICMR for speedy progress: PM

Hyderabad, Nov 28 (IANS) Prime Minister Narendra Modi said Bharat Biotech, a city-based pharmaceutical company, is closely working with the Indian Council of Medical...